| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.128 | 16.111 | 17.423 | 18.213 | 23.327 | 25.312 | 37.330 | 38.492 | 59.498 |
| Total Income - EUR | - | 9.128 | 16.113 | 17.424 | 18.216 | 23.329 | 25.720 | 37.336 | 38.502 | 59.503 |
| Total Expenses - EUR | - | 990 | 12.579 | 8.646 | 14.921 | 12.575 | 11.010 | 13.925 | 30.651 | 44.081 |
| Gross Profit/Loss - EUR | - | 8.138 | 3.533 | 8.778 | 3.295 | 10.754 | 14.711 | 23.411 | 7.851 | 15.421 |
| Net Profit/Loss - EUR | - | 7.865 | 3.050 | 8.255 | 2.749 | 10.054 | 14.043 | 22.291 | 6.579 | 12.928 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Cryoderm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 1.760 | 1.222 | 3.222 | 2.005 |
| Current Assets | - | 8.394 | 13.555 | 9.372 | 5.154 | 12.339 | 21.231 | 43.438 | 18.512 | 18.635 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 |
| Receivables | - | 1.218 | 1.485 | 1.000 | 1.270 | 4.845 | 1.691 | 18.931 | 1.896 | 4.668 |
| Cash | - | 7.176 | 12.070 | 8.372 | 3.884 | 7.494 | 19.540 | 24.507 | 16.616 | 13.955 |
| Shareholders Funds | - | 7.909 | 3.098 | 8.303 | 2.799 | 10.102 | 19.917 | 22.340 | 11.695 | 12.976 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 485 | 10.457 | 1.069 | 2.355 | 236 | 1.524 | 22.320 | 10.039 | 7.664 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 2.001 | 1.550 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cryoderm S.r.l.